WE SHOULD PARTNER
Zylö Therapeutics’ business development efforts are focused on identifying regional or global development partners across the Rx-OTC-cosmeceutical regulatory spectrum, with an interest in leveraging our innovative Z-pod™ topical delivery platform to meet unmet clinical and cosmetic needs.
Examples of collaborative development programs Zylo is working on include:
Loading of a "proprietary" active ingredient into the Z-pod™ to enhance solubility or to reduce reactivity prior to use
Loading of an active ingredient with established proof of concept (precursors of Nitric Oxide, lidocaine, capsaicin) into the Z-pod™ for purposes of sustained release into the skin
Loading of novel actives—such as cannabinoids, curcumin, SiRNA (other)—into the Z-pod™ for purposes of effective penetration into the skin, the pores, the follicles, or the sebaceous glands
Loading of a "proprietary" active ingredient into the Z-pod™ to improve targeting of the pores, the follicles, or the sebaceous glands
To discuss Zylo’s delivery platform in more detail and to explore potential business development opportunities, please contact us at the following email address: